Melanoma Clinical Trials in Michigan

Showing 221-225 of 225 trials

A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

NCT00733798

The purpose of this study is to evaluate the safety and effectiveness of 131I-TM601 in the treatment of adult patients with progressive and/or recurrent malignant melanoma.

MelanomaMalignant MelanomaMetastatic Melanoma

TransMolecular58 participants

Grand Rapids, Michigan, United States • New York, New York, United States • Dallas, Texas, United States

UNKNOWNPhase 362 miles

Vaccine Therapy for Patients With Stage IV Melanoma

NCT00052156

This is a Phase III study in patients with melanoma that has spread to the lymph nodes and/or a distant organ, and who have had all of their cancer surgically removed. The purpose of this study is to evaluate the ability of the CancerVax™ vaccine to prevent or slow the recurrence of melanoma.

Malignant Melanoma

CancerVax Corporation670 participants

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Little Rock, Arkansas, United States +74 more locations

A Safety and Efficacy Study of Intravenous 131I-TM601 in Adult Patients With Malignant Melanoma

Vaccine Therapy for Patients With Stage IV Melanoma

Melanoma Trials in Other Cities

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Randomized Trial of ATN-224 and Temozolomide in Advanced Melanoma

Other Conditions in Michigan